A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
We describe a murine model of postoperative ileus generated via intestinal manipulation. Gastrointestinal transit function, pathologic changes, and immune cell activation were assessed 24 h after surgery.
Most patients experience postoperative ileus (POI) after surgery, which is associated with increased morbidity, mortality, and hospitalization time. POI is a consequence of mechanical damage during surgery, resulting in disruption of motility in the gastrointestinal tract. The mechanisms of POI are related to aberrant neuronal sensitivity, impaired epithelial barrier function, and increased local inflammation. However, the details remain enigmatic. Therefore, experimental murine models are crucial for elucidating the pathophysiology and mechanism of POI injury and for the development of novel therapies.
Here, we introduce a murine model of POI generated via intestinal manipulation (IM) that is similar to clinical surgery; this is achieved by mechanical damage to the small intestine by massaging the abdomen 1-3 times with a cotton swab. IM delayed gastrointestinal transit 24 h after surgery, as assessed by FITC-dextran gavage and fluorescence detection of the segmental digestive tract. Moreover, tissue swelling of the submucosa and immune cell infiltration were investigated by hematoxylin and eosin staining and flow cytometry. Proper pressure of the IM and a hyperemic effect on the intestine are critical for the procedure. This murine model of POI can be utilized to study the mechanisms of intestinal damage and recovery after abdominal surgery.
Postoperative ileus (POI) is a syndrome that poses a significant challenge in the field of human health, particularly in the management of patients undergoing abdominal surgery. Characterized by delayed recovery of gastrointestinal motility, POI contributes to prolonged hospital stays and increased health care costs, yet no established definition, etiology, or treatment exists1. Recent research has shed light on the pivotal role of immune cells in the progression of POI2,3,4, yet further investigation is required to elucidate the underlying mechanisms ....
Animal care and experimental procedures were conducted in accordance with the Guiding Principles in the Care and Use of Animals (China) and were approved by the Ethics Review Committee of Beijing Friendship Hospital (NO. 20-2056). C57BL/6 mice (8-12 weeks old) were used for the study.
1. Preparation for surgery
In this protocol, POI was surgically induced by intestinal manipulation (IM), which is similar to the effect of clinical surgery. In the sham group, an incision was made without the IM. POI mice were sacrificed 24 h post-POI surgery along with sham control mice. The critical function of the digestive tract, content transit function, was detected by gavage of FITC-dextran. The POI model was considered successful because the FITC intensity increased in the proximal part of the small intestine (Fig.......
The success of surgery relies on several critical steps. First, maintaining consistency during intestinal intramural (IM) surgery is imperative to induce extensive injury to the small intestine. Proper pressure applied during the IM procedure and the resulting hyperemic effect on the intestine are crucial for surgical success. The observation of the entire digestive tract turning pink and displaying red hemorrhagic spots after rubbing with a cotton swab served as an indicator of a successful operation. Additionally, ensu.......
We are grateful to the Laboratory Animal Center, Beijing Clinical Research Institute, and Beijing Friendship Hospital for providing animal care. This work was supported by the National Key Technologies R&D Program (No. 2015BAI13B09), Beijing Natural Science Foundation (No. 7232035), National Natural Science Foundation of China (No. 82171823, 82374190), and Distinguished Young Scholars from Beijing Friendship Hospital (No. yyqcjh2022-4).
....Name | Company | Catalog Number | Comments |
1 M HEPES | Thermo | 15630080 | |
APC anti-mouse I-A/I-E (MHC-II) | Biolegend | 107614 | |
APC anti-mouse TCRb | Biolegend | 109212 | |
APC/Cy7 anti-mouse CD4 | Biolegend | 100414 | |
APC/Cy7 anti-mouse Ly6G | Biolegend | 127624 | |
Brilliant Violet 421 anti-mouse CD69 | Biolegend | 104545 | |
Brilliant Violet 421 anti-mouse F4/80 | Biolegend | 123132 | |
Brilliant Violet 785 anti-mouse/human CD44 | Biolegend | 103041 | |
BUV395 anti-mouse CD8a | BD | 563786 | |
BUV737 anti-mouse CD3e | BD | 612771 | |
Collagenase IV | Sigma-Aldrich | C5138 | |
Culture Microscope | CKX53 | Olympus | |
Deoxyribonuclease I from bovine pancreas (DNase I) | Sigma-Aldrich | DN25-5G | |
DL-Dithiothreitol solution | Sigma-Aldrich | 43816-10ML | |
EDTA | Sigma-Aldrich | EDS-100G | |
FITC anti-mouse CD45 | Biolegend | 147709 | |
FITC-dextran (70 kWM) | Sigma-Aldrich | FD70-100MG | Gastrointestinal Transit Assay |
HE staining kit | solarbio | G1120 | |
PE anti-mouse CD11b | Biolegend | 101208 | |
PE anti-mouse PD-1 | Biolegend | 114118 | |
PE/Cy7 anti-mouse CD11c | Biolegend | 117318 | |
Percoll | GE (Pharmacia) | 17-0891-01 | |
Symphony A5 Flow cytometer | BD | - | Immune cell detection and sorting |
Tribromoethanol | Sigma-Aldrich | T48402 | Anesthesia |
Varioskan LUX | Thermo | N16699 | Multimode microplate reader |
Zombie Aqua Fixable Viability kit | Biolegend | 423102 | Fluorescent viability dye |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved